American Cannabis Stock Performance
| AMMJ Stock | USD 0.01 0 10.00% |
On a scale of 0 to 100, American Cannabis holds a performance score of 3. The firm shows a Beta (market volatility) of 1.18, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, American Cannabis will likely underperform. Please check American Cannabis' coefficient of variation, potential upside, day median price, as well as the relationship between the sortino ratio and skewness , to make a quick decision on whether American Cannabis' price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in American Cannabis are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain primary indicators, American Cannabis revealed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -1.5 M |
American |
American Cannabis Relative Risk vs. Return Landscape
If you would invest 1.10 in American Cannabis on January 24, 2024 and sell it today you would lose (0.20) from holding American Cannabis or give up 18.18% of portfolio value over 90 days. American Cannabis is currently generating 0.6177% in daily expected returns and assumes 13.5337% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than American, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
American Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for American Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as American Cannabis, and traders can use it to determine the average amount a American Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0456
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AMMJ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.53 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average American Cannabis is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of American Cannabis by adding it to a well-diversified portfolio.
American Cannabis Fundamentals Growth
American OTC Stock prices reflect investors' perceptions of the future prospects and financial health of American Cannabis, and American Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on American OTC Stock performance.
| Return On Equity | -0.93 | |||
| Return On Asset | -0.23 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 85.73 M | |||
| Price To Earning | 62.93 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 2.43 M | |||
| EBITDA | (1.27 M) | |||
| Cash And Equivalents | 873.76 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 806.73 K | |||
| Debt To Equity | 0.49 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (957.92 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (4.5 M) | |||
| Current Asset | 379 K | |||
| Current Liabilities | 541 K | |||
About American Cannabis Performance
To evaluate American Cannabis OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when American Cannabis generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare American OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand American Cannabis market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents American's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.American Cannabis Company, Inc., together with its subsidiary, Hollister Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado. American Cannabis operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 7 people.Things to note about American Cannabis performance evaluation
Checking the ongoing alerts about American Cannabis for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for American Cannabis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| American Cannabis is way too risky over 90 days horizon | |
| American Cannabis has some characteristics of a very speculative penny stock | |
| American Cannabis appears to be risky and price may revert if volatility continues | |
| American Cannabis has high likelihood to experience some financial distress in the next 2 years | |
| The company currently holds 806.73 K in liabilities with Debt to Equity (D/E) ratio of 0.49, which is about average as compared to similar companies. American Cannabis has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist American Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, American Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like American Cannabis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for American to invest in growth at high rates of return. When we think about American Cannabis' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.43 M. Net Loss for the year was (1.44 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| American Cannabis currently holds about 873.76 K in cash with (957.92 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of American Cannabis shares are held by company insiders |
- Analyzing American Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether American Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining American Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating American Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of American Cannabis' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of American Cannabis' otc stock. These opinions can provide insight into American Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Cannabis. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for American OTC Stock analysis
When running American Cannabis' price analysis, check to measure American Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy American Cannabis is operating at the current time. Most of American Cannabis' value examination focuses on studying past and present price action to predict the probability of American Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move American Cannabis' price. Additionally, you may evaluate how the addition of American Cannabis to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |